Prescription Drug Information: Vancomycin Hydrochloride (Page 3 of 3)

HOW SUPPLIED/STORAGE AND HANDLING

Vancomycin Hydrochloride for Injection, USP is supplied as:

Product Code

Unit of Sale Strength Each
PRX22138

NDC 63323-221-48

Unit of 25

500 mg per vial

NDC 63323-221-43

PRX28435

NDC 63323-284-45

Unit of 10

1 gram per vial

NDC 63323-284-41

Prior to reconstitution, the vials may be stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].

The container closure is not made with natural rubber latex.

ANIMAL PHARMACOLOGY

In animal studies, hypotension and bradycardia occurred in dogs receiving an intravenous infusion of vancomycin 25 mg/kg, at a concentration of 25 mg/mL and an infusion rate of 13.3 mL/min.

REFERENCES

1. Moellering RC, Krogstad DJ, Greenblatt DJ: Vancomycin therapy in patients with impaired renal function: A nomogram for dosage. Ann Inter Med 1981;94:343.

PREMIERProRx® is a registered trademark of Premier Healthcare Alliance, L.P., used under license.

Manufactured for:
fk-logo

Fresenius Kabi USA, LLC
Lake Zurich, IL 60047

Made in Denmark

www.fresenius-kabi.com/us

451557A
Revised: November 2018

premier-logofk-logopremier-logo

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL-500mg

VIAL LABEL

NDC 63323-221-43
Vancomycin Hydrochloride for Injection, USP
500 mg* per vial
For intravenous use.
MUST BE FURTHER DILUTED BEFORE USE.
Sterile, Lyophilized.
Preservative free. Rx only.

vial 500mg
(click image for full-size original)

CARTON

NDC 63323-221-48
Vancomycin Hydrochloride for Injection, USP
500 mg* per vial
For intravenous use.
MUST BE FURTHER DILUTED BEFORE USE.
Preservative free.
25 vials x 500 mg Rx only

carton pdp
(click image for full-size original)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL-1g

VIAL LABEL

NDC 63323-284-41
Vancomycin Hydrochloride for Injection, USP
1 gram* per vial
For Intravenous Use.
Must be Further Diluted Before Use.
Sterile, Lyophilized.
Preservative free. Rx only.

vial 1g
(click image for full-size original)

CARTON

NDC 63323-284-45
Vancomycin Hydrochloride for Injection, USP
1 gram* per vial
For intravenous use.
MUST BE FURTHER DILUTED BEFORE USE.
Preservative free.
10 x 1 g vials Rx only

carton 1g
(click image for full-size original)
VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:63323-221
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN) VANCOMYCIN 500 mg in 10 mL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:63323-221-48 25 VIAL in 1 TRAY contains a VIAL (63323-221-43)
1 NDC:63323-221-43 10 mL in 1 VIAL This package is contained within the TRAY (63323-221-48)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204107 10/26/2017
VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:63323-284
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN) VANCOMYCIN 1 g in 20 mL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:63323-284-45 10 VIAL in 1 TRAY contains a VIAL (63323-284-41)
1 NDC:63323-284-41 20 mL in 1 VIAL This package is contained within the TRAY (63323-284-45)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204107 10/26/2017
Labeler — Fresenius Kabi, LLC (608775388)
Establishment
Name Address ID/FEI Operations
Xellia Pharmaceuticals ApS 305814345 manufacture (63323-221), api manufacture (63323-221), label (63323-221), pack (63323-221), analysis (63323-221), manufacture (63323-284), api manufacture (63323-284), label (63323-284), pack (63323-284), analysis (63323-284)

Revised: 12/2022 Fresenius Kabi, LLC

Page 3 of 3 1 2 3

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.